MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Collection of Lung Fluid and Tissue Samples for Research

Recruiting
Conditions
Respiratory Tract Diseases
Leukocyte Disorders
Bronchoscopy
First Posted Date
2007-05-09
Last Posted Date
2024-12-17
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
550
Registration Number
NCT00471250
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Stem Cell Transplantation for Patients With Cancers of the Blood

Phase 2
Completed
Conditions
CLL (Chronic Lymphocytic Leukemia)
AML (Acute Myelogenous Leukemia)
CML (Chronic Myelogenous Leukemia)
Acute Lymphocytic Leukemia
MDS (Myelodysplastic Syndrome)
Interventions
Combination Product: Miltenyi system
First Posted Date
2007-05-01
Last Posted Date
2018-07-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
61
Registration Number
NCT00467961
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Imaging of Totally Blocked Arteries

Phase 1
Completed
Conditions
Atherosclerosis
Peripheral Artery Disease
Intermittent Claudication
Chronic Total Aterial Occlusion
First Posted Date
2007-04-12
Last Posted Date
2017-07-02
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
20
Registration Number
NCT00459446
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Model System for Transient Forearm Blood Vessel Dysfunction

Phase 1
Completed
Conditions
Limb Ischemia
Ischemic Preconditioning
Interventions
Procedure: Limb Ischemia
First Posted Date
2007-03-29
Last Posted Date
2022-08-09
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
6
Registration Number
NCT00453531
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

The Link Between Anemia and Deficits in Memory and Attention in Individuals With Sickle Cell Disease

Completed
Conditions
Sickle Cell Disease
First Posted Date
2007-03-26
Last Posted Date
2016-08-19
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
120
Registration Number
NCT00451919
Locations
🇺🇸

University of California San Francisco, San Francisco, California, United States

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma

Phase 1
Terminated
Conditions
Stage IV Melanoma
Recurrent Melanoma
First Posted Date
2007-03-05
Last Posted Date
2024-03-04
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00003552
Locations
🇺🇸

National Heart, Lung, and Blood Institute, Bethesda, Maryland, United States

Transfusion-Associated Microchimerism in Previously Injured Individuals Who Received a Blood Transfusion

Terminated
Conditions
Blood Transfusion
Wounds and Injuries
Chimerism
First Posted Date
2007-03-01
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
59
Registration Number
NCT00441779
Locations
🇺🇸

University of California, Davis, Medical Center, Sacramento, California, United States

Collection and Analysis of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers

Recruiting
Conditions
Healthy Volunteers
First Posted Date
2007-03-01
Last Posted Date
2025-04-23
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
1000
Registration Number
NCT00442195
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Drug Study of Albuterol to Treat Acute Lung Injury

Phase 2
Terminated
Conditions
Respiratory Distress Syndrome, Adult
Interventions
Drug: Placebo
Procedure: Mini-Bronchoalveolar Lavage (BAL)
First Posted Date
2007-02-14
Last Posted Date
2017-02-10
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
282
Registration Number
NCT00434993
Locations
🇺🇸

University of California, Davis Medical Center, Sacramento, California, United States

🇺🇸

Rose Medical Center, Denver, Colorado, United States

🇺🇸

University of Colorado Health Sciences Center, Denver, Colorado, United States

and more 37 locations

Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy

Phase 2
Completed
Conditions
Chronic Myeloid Leukemia (CML)
Myelodysplastic Syndrome
Acute Myeloid Leukemia (AML)
Interventions
First Posted Date
2007-02-12
Last Posted Date
2014-07-08
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
4
Registration Number
NCT00433745
Locations
🇺🇸

National Cancer Institute (NCI), 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath